These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 7018459

  • 41. Discontinuing Hemodialysis through Corticosteroid Treatment in a Patient with Cryofibrinogen-associated Glomerulonephritis.
    Arai S, Matsui R, Ono W, Asakawa S, Yamazaki O, Tamura Y, Terasaki M, Hagiwara K, Nakagawa T, Ohashi R, Shimizu A, Shibata S, Fujigaki Y.
    Intern Med; 2024 Jul 01; 63(13):1899-1905. PubMed ID: 37926528
    [Abstract] [Full Text] [Related]

  • 42. Corticosteroid therapy is beneficial in adults with idiopathic membranous glomerulopathy.
    Glassock RJ.
    Am J Kidney Dis; 1982 May 01; 1(6):376-85. PubMed ID: 7091153
    [No Abstract] [Full Text] [Related]

  • 43. [Corticosteroid therapy in glomerulonephritis].
    Ratner MIa, Serov VV, Dordon RI, Lobanova ED.
    Sov Med; 1967 Jan 01; 30(1):27-35. PubMed ID: 5611320
    [No Abstract] [Full Text] [Related]

  • 44. The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists.
    Barbour S, Beaulieu M, Gill J, Espino-Hernandez G, Reich HN, Levin A.
    Clin Kidney J; 2014 Dec 01; 7(6):538-45. PubMed ID: 25859369
    [Abstract] [Full Text] [Related]

  • 45. [The use of steroid hormones in various forms and variants of the course of diffuse glomerulonephritis].
    Paleeva FM.
    Ter Arkh; 1967 Nov 01; 39(11):68-72. PubMed ID: 5611739
    [No Abstract] [Full Text] [Related]

  • 46. Corticosteroid therapy in glomerulonephritis.
    Shigematsu H.
    Intern Med; 1998 Aug 01; 37(8):651. PubMed ID: 9745848
    [No Abstract] [Full Text] [Related]

  • 47. [Use of corticotherapy in the treatment of idiopathic glomerulonephritis].
    Piccoli G, Coppo R, Roccatello D, Bosticardo GM, Aprato A, Belardi P, Bossi P, Messina M, Salomone M.
    Arch Sci Med (Torino); 1981 Aug 01; 138(1):17-32. PubMed ID: 7018459
    [Abstract] [Full Text] [Related]

  • 48. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A, Simon P.
    Adv Nephrol Necker Hosp; 1988 Aug 01; 17():127-50. PubMed ID: 3124536
    [Abstract] [Full Text] [Related]

  • 49. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C, Brosius FC, Palmieri J.
    Clin Pharm; 1993 Jun 01; 12(6):429-39. PubMed ID: 8403814
    [Abstract] [Full Text] [Related]

  • 50. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005 Jun 01; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 51. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Jun 01; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 52. [Use of corticotherapy in the treatment of idiopathic glomerulonephritis].
    Piccoli G, Coppo R, Roccatello D, Bosticardo GM, Aprato A, Belardi P, Bossi P, Messina M, Salomone M.
    Arch Sci Med (Torino); 1981 Jun 01; 138(1):17-32. PubMed ID: 7018459
    [Abstract] [Full Text] [Related]

  • 53. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A, Simon P.
    Adv Nephrol Necker Hosp; 1988 Jun 01; 17():127-50. PubMed ID: 3124536
    [Abstract] [Full Text] [Related]

  • 54. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C, Brosius FC, Palmieri J.
    Clin Pharm; 1993 Jun 01; 12(6):429-39. PubMed ID: 8403814
    [Abstract] [Full Text] [Related]

  • 55. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005 Jun 01; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 56. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Jun 01; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 57. [Use of corticotherapy in the treatment of idiopathic glomerulonephritis].
    Piccoli G, Coppo R, Roccatello D, Bosticardo GM, Aprato A, Belardi P, Bossi P, Messina M, Salomone M.
    Arch Sci Med (Torino); 1981 Jun 01; 138(1):17-32. PubMed ID: 7018459
    [Abstract] [Full Text] [Related]

  • 58. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A, Simon P.
    Adv Nephrol Necker Hosp; 1988 Jun 01; 17():127-50. PubMed ID: 3124536
    [Abstract] [Full Text] [Related]

  • 59. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C, Brosius FC, Palmieri J.
    Clin Pharm; 1993 Jun 01; 12(6):429-39. PubMed ID: 8403814
    [Abstract] [Full Text] [Related]

  • 60. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP.
    J Nephrol; 1999 Jun 01; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.